Sedation-Paralysis as Cornerstone on Rabies Management (Milwaukee Protocol)

  • Ali Jabbari Ischemic Disorders Research Center of Golestan University of Medical Sciences, Gorgan, Iran.
  • Behnaz Khodabakhshi Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Shabnam Tabasi Department of Internal Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Keywords: Sedation-paralysis; Rabies; Milwaukee protocol

Abstract

Rabies is a viral infection involving the central nervous system that is almost always fatal without proper post exposure prophylaxis. Here, we present a 38 years-old male with dog-bite and late attention whom, managed in intensive care unit. After 21 days, the disease progressed to serious neurologic and hemodynamic damage including motor disorders and imbalance in blood pressure and cardiac rhythm. Clinical management of the patient consisted of antiviral agents (Amantadine and Ribavirin), neuroprotection, sedation-paralysis and supportive care. Patient was survived 43 days from the clinical disease onset. Although our patient died in spite of intensive care, advances in the use of sedation-paralysis and early prescription of antiviral agents raised hopes that it may eventually be possible to save rabies patients.

Published
2022-01-04
Section
Articles